# Seneca Foods Corp: overview

SENEA · Nasdaq · CIK 88948 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/senea.md) · [Financials](/companies/senea/financials.md) · [Filings](/companies/senea/filings.md) · [Insiders](/companies/senea/insiders.md)

Latest reported revenue: [$405.2m](/filings/0001437749-26-026264.md) for Q1 FY2026, three months to 2026-06-27, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001437749-26-026264).

## Last eight quarters

| Line item | Unit | Q1 FY2024 (2024-06-29) | Q2 FY2024 (2024-09-28) | Q3 FY2024 (2024-12-28) | Q4 FY2024 (2025-03-31) | Q1 FY2025 (2025-06-28) | Q2 FY2025 (2025-09-27) | Q3 FY2025 (2025-12-27) | Q1 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [305](/filings/0001437749-25-025429.md) | [425](/filings/0001437749-25-033352.md) | [503](/filings/0001437749-26-003202.md) | [346 d](/filings/0001437749-25-020197.md) | [297](/filings/0001437749-26-026264.md) | [460](/filings/0001437749-25-033352.md) | [508](/filings/0001437749-26-003202.md) | [405](/filings/0001437749-26-026264.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [8.3%](/filings/0001437749-25-025429.md) | [5.8%](/filings/0001437749-25-033352.md) | [5.1%](/filings/0001437749-26-003202.md) | [0.6% d](/filings/0001437749-25-020197.md) | [7.8%](/filings/0001437749-26-026264.md) | [9.0%](/filings/0001437749-25-033352.md) | [11.8%](/filings/0001437749-26-003202.md) | [6.5%](/filings/0001437749-26-026264.md) |
| Net margin | % | [4.2%](/filings/0001437749-26-003202.md) | [3.1%](/filings/0001437749-26-003202.md) | [2.9%](/filings/0001437749-26-003202.md) | [0.2% d](/filings/0001437749-25-020197.md) | [5.0%](/filings/0001437749-26-026264.md) | [6.5%](/filings/0001437749-26-003202.md) | [8.8%](/filings/0001437749-26-003202.md) | [4.8%](/filings/0001437749-26-026264.md) |
| Diluted EPS | $ per share | [1.80](/filings/0001437749-25-025429.md) | [1.90](/filings/0001437749-25-033352.md) | [2.10](/filings/0001437749-26-003202.md) | not reported | [2.14](/filings/0001437749-26-026264.md) | [4.29](/filings/0001437749-25-033352.md) | [6.48](/filings/0001437749-26-003202.md) | [2.85](/filings/0001437749-26-026264.md) |
| Free cash flow | $m | [38.3](/filings/0001437749-25-025429.md) | [70.0 d](/filings/0001437749-25-033352.md) | [109 d](/filings/0001437749-26-003202.md) | [81.4 d](/filings/0001437749-25-020197.md) | [42.4](/filings/0001437749-26-026264.md) | [21.8 d](/filings/0001437749-25-033352.md) | [22.9 d](/filings/0001437749-26-003202.md) | [91.9](/filings/0001437749-26-026264.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2020 (2021-03-31) | FY2021 (2022-03-31) | FY2022 (2023-03-31) | FY2023 (2024-03-31) | FY2024 (2025-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,468](/filings/0001437749-23-021172.md) | [1,385](/filings/0001437749-24-020198.md) | [1,509](/filings/0001437749-25-020197.md) | [1,459](/filings/0001437749-25-020197.md) | [1,579](/filings/0001437749-25-020197.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [12.3%](/filings/0001437749-23-021172.md) | [4.6%](/filings/0001437749-24-020198.md) | [1.4%](/filings/0001437749-25-020197.md) | [7.4%](/filings/0001437749-25-020197.md) | [4.9%](/filings/0001437749-25-020197.md) |
| Net margin | % | [8.6%](/filings/0001437749-23-021172.md) | [3.3%](/filings/0001437749-24-020198.md) | [0.6%](/filings/0001437749-25-020197.md) | [4.3%](/filings/0001437749-25-020197.md) | [2.6%](/filings/0001437749-25-020197.md) |
| Diluted EPS | $ per share | [13.72](/filings/0001437749-23-021172.md) | [5.24](/filings/0001437749-24-020198.md) | [1.16](/filings/0001437749-25-020197.md) | [8.56](/filings/0001437749-25-020197.md) | [5.90](/filings/0001437749-25-020197.md) |
| Free cash flow | $m | [112](/filings/0001437749-23-021172.md) | [(23.2)](/filings/0001437749-24-020198.md) | [(283)](/filings/0001437749-25-020197.md) | [(120)](/filings/0001437749-25-020197.md) | [298](/filings/0001437749-25-020197.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/senea/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $78.0m | 448,251 |  | Added +15,641 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $73.7m | 423,872 |  | Added +3,573 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $50.7m | 291,319 |  | Added +63,209 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $34.4m | 197,665 |  | Added +113 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $32.6m | 187,688 |  | Added +59,782 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $30.8m | 203,539 |  | Reduced −31,676 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $27.8m | 159,599 |  | Added +5,232 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $22.1m | 127,248 |  | Added +5,034 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $15.2m | 87,317 |  | Reduced −14,220 |
| [LAZARD ASSET MANAGEMENT LLC](/funds/1207017.md) | 2026-06-30 | $13.5m | 77,387 |  | Added +19,917 |

## Recent filings

[All 560 filings](/companies/senea/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 17:38 ET | [DEF 14A](/filings/0001437749-26-031991.md) | Proxy statement, period 2026-11-04 | 0001437749-26-031991 |
| 2026-09-21 | 20:15 ET | [8-K](/filings/0001437749-26-030826.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-26-030826 |
| 2026-08-11 | 20:10 ET | [8-K](/filings/0001437749-26-027008.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-027008 |
| 2026-08-06 | 20:10 ET | [10-Q](/filings/0001437749-26-026264.md) | Quarterly report, period 2026-06-27 | 0001437749-26-026264 |
| 2026-07-07 | 20:10 ET | [DEF 14A](/filings/0001437749-26-022933.md) | Proxy statement, period 2026-08-06 | 0001437749-26-022933 |
| 2026-06-11 | 20:06 ET | [10-K](/filings/0001437749-26-020290.md) | Annual report, period 2026-03-31 | 0001437749-26-020290 |
| 2026-02-05 | 21:14 ET | [10-Q](/filings/0001437749-26-003202.md) | Quarterly report, period 2025-12-27 | 0001437749-26-003202 |
| 2025-11-05 | 21:13 ET | [10-Q](/filings/0001437749-25-033352.md) | Quarterly report, period 2025-09-27 | 0001437749-25-033352 |
| 2025-08-12 | 20:10 ET | [8-K](/filings/0001437749-25-026194.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-026194 |
| 2025-08-07 | 20:11 ET | [10-Q](/filings/0001437749-25-025429.md) | Quarterly report, period 2025-06-28 | 0001437749-25-025429 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001437749-26-020290.md), filed Jun 11, 2026.

## Forecast league

Q2 FY2026, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/a5aca530-4caf-4e4a-933b-faffb58429b4)

## About the filer

- CIK: 88948
- Tickers: SENEA, SENEB, SENEL, SENEM
- Exchange: Nasdaq
- SIC code: 2033 Canned, Fruits, Veg, Preserves, Jams & Jellies
- State of incorporation: NY
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.